14
Participants
Start Date
October 31, 2016
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Neratinib
Neratinib will be administered orally, or through existing gastrostomy feeding tube, once a day with food, preferably in the morning, continuously for 28-day cycles, with no rest between cycles. Dose will be scaled by body surface area (BSA).
Memorial Sloan Kettering Cancer Center, New York
Pennsylvania State Hershey Children's Hospital, Hershey
Arnold Palmer Hospital for Children, Orlando
Arkansas Children's Hospital, Little Rock
University of Texas, San Antonio
Huntsman Cancer Institue, Salt Lake City
Phoenix Children'S Hospital, Phoenix
Stanford University School of Medicine and Stanford Cancer Institute, Palo Alto
Alberta Children'S Hospital, Calgary
Milton S. Hershey Medical Center
OTHER
M.D. Anderson Cancer Center
OTHER
Stanford University
OTHER
Arkansas Children's Hospital Research Institute
OTHER
Alberta Children's Hospital
OTHER
Phoenix Children's Hospital
OTHER
University of Texas
OTHER
Memorial Sloan Kettering Cancer Center
OTHER